Posts for Hepion Pharmaceuticals, Inc. ($HEPA)

Explore Hepion Pharmaceuticals' latest 8-K filing revealing crucial financial developments as of January 14, 2025. Key details on stock performance and SEC compliance.

Discover critical updates in Hepion Pharmaceuticals' Amendment No. 2 to Form 10-K/A, detailing executive compensation errors, stock ownership details, and compliance with Sarbanes-Oxley.